Mark E. Cooper
Impact in
- Nephrology top 0.01%
- Chronic Kidney Disease and Diabetes
- Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research
Papers in
- Nephrology 161
- Chronic Kidney Disease and Diabetes 147
-
- Diabetes Treatment and Management 75
- Hormonal Regulation and Hypertension 29
- Diabetes, Cardiovascular Risks, and Lipoproteins 24
- Co-authors
- Josephine M. Forbes (70 shared papers)Merlin C. Thomas (80 shared papers)Karin Jandeleit‐Dahm (76 shared papers)Dick de Zeeuw (21 shared papers)Giuseppe Remuzzi (18 shared papers)Shahnaz Shahinfar (19 shared papers)Barry M. Brenner (18 shared papers)William F. Keane (10 shared papers)
- Journals
- Diabetes (36 papers)Kidney International (36 papers)Diabetologia (30 papers)Journal of the American Society of Nephrology (25 papers)Journal of Hypertension (24 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark E. Cooper
513 papers receiving 49.6k citations
Mark E. Cooper's Hit Papers
Peers
Comparison fields: 5 of 178
- Nephrology 11.5k
- Clinical Biochemistry 7.9k
- Endocrinology, Diabetes and Metabolism 14.9k
- Cardiology and Cardiovascular Medicine 10.3k
- Physiology 4.7k
Countries citing papers authored by Mark E. Cooper
This map shows the geographic impact of Mark E. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Cooper more than expected).
Fields of papers citing papers by Mark E. Cooper
This network shows the impact of papers produced by Mark E. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Cooper. The network helps show where Mark E. Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 530 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy Hit paper breakdown → | 2001 | 5706 |
| 2 | Mechanisms of Diabetic Complications Hit paper breakdown → | 2013 | 2175 |
| 3 | A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease Hit paper breakdown → | 2009 | 1518 |
| 4 | Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future Hit paper breakdown → | 2013 | 1303 |
| 5 | Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes Hit paper breakdown → | 2008 | 1023 |
| 6 | Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia Hit paper breakdown → | 2008 | 904 |
| 7 | The Role of Advanced Glycation End Products in Progression and Complications of Diabetes Hit paper breakdown → | 2008 | 846 |
| 8 | Diabetic kidney disease Hit paper breakdown → | 2015 | 845 |
| 9 | Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk Hit paper breakdown → | 2018 | 794 |
| 10 | Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL Hit paper breakdown → | 2004 | 769 |
| 11 | Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes Hit paper breakdown → | 2009 | 713 |
| 12 | Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy Hit paper breakdown → | 2004 | 589 |
| 13 | Reduced Bone Mass in Daughters of Women with Osteoporosis Hit paper breakdown → | 1989 | 552 |
| 14 | Diabetes and Kidney Disease: Role of Oxidative Stress Hit paper breakdown → | 2016 | 538 |
| 15 | Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease Hit paper breakdown → | 2015 | 538 |
| 16 | Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy Hit paper breakdown → | 2015 | 527 |
| 17 | 1998 | 453 | |
| 18 | Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail Hit paper breakdown → | 2009 | 441 |
| 19 | 2011 | 435 | |
| 20 | 2009 | 397 |
About Mark E. Cooper
Mark E. Cooper is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 530 papers that have together received 51.4k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (147 papers), Advanced Glycation End Products research (121 papers), Diabetes Treatment and Management (75 papers), Renin-Angiotensin System Studies (57 papers), Blood Pressure and Hypertension Studies (55 papers), Hormonal Regulation and Hypertension (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Pancreatic function and diabetes (23 papers). The work is most often cited by research in Nephrology (11.5k citations), Clinical Biochemistry (7.9k citations), Endocrinology, Diabetes and Metabolism (14.9k citations), Cardiology and Cardiovascular Medicine (10.3k citations) and Physiology (4.7k citations). Mark E. Cooper has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Josephine M. Forbes, Merlin C. Thomas, Karin Jandeleit‐Dahm, Dick de Zeeuw, Giuseppe Remuzzi, Shahnaz Shahinfar, Barry M. Brenner, William F. Keane, Hans‐Henrik Parving and William E. Mitch. Their work appears in journals such as Diabetes, Kidney International, Diabetologia, Journal of the American Society of Nephrology and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.